Ticker	Volume	Price	Price Delta
DJIA	15,303.10	+8.60	0.06%
S&P 500	1,649.60	-0.91	-0.06%
Nasdaq	3,459.14	-0.27	-0.01%

Ticker

Volume

Price

Price Delta

DJIA

15,303.10

+8.60

0.06%

S&P 500

1,649.60

-0.91

-0.06%

Nasdaq

3,459.14

-0.27

-0.01%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Nufarm Said to Plan to Sign A$900 Million of Loans This Week

By Katrina Nicholas - 2011-11-16T05:15:02Z

Nufarm Ltd., a Melbourne-based maker of agricultural chemicals, expects to sign loan facilities worth A$900 million as early as tomorrow, according to a person familiar with the matter.

One A$300 million trade receivables facility is being provided by Rabobank International while another term loan of A$600 million is being provided by Australia & New Zealand Banking Group Ltd. (ANZ), Credit Suisse Group AG, Deutsche Bank AG, Rabobank, Mizuho Corporate Bank Ltd., UBS AG and UniCredit SpA (UCG) in roughly equal amounts, the person said, asking not to be identified as details are private.

Proceeds will be used to refinance debt, the person said. Nufarm has A$900 million of bank debt maturing this year, according to data compiled by Bloomberg.

To contact the editor responsible for this story: Katrina Nicholas at knicholas2@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.